Search companies or stocks...
ETNB89bio, Inc.
At close · 30 Oct 2025, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic…
Current stock price of 89bio, Inc. (ETNB) stock is $14.840. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of 89bio, Inc. (ETNB) stock is 38.51M.
Last updated at 30 Oct 2025, 08:00 pm.
The stock price of 89bio, Inc. (ETNB) can change with earnings, company news, and overall market sentiment. 89bio, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether 89bio, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ETNB on this page is -4.02. EPS on this page is -3.69. Compare those figures with peers and growth expectations before deciding if the current 89bio, Inc. price is justified.
Historical performance for 89bio, Inc. (ETNB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ETNB reacted to past earnings and market events.
Buying 89bio, Inc. (ETNB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
